Jones, Mark M.

Ruxolitinib safety experience in the polycythemia vera clinical trial program.

Martino, Bruno, He, Shui, Habr, Dany , Alecu, Iulian , Verstovšek, Srđan , Mesa, Ruben A. , Kiladjian, Jean‐Jacques , Jones, Mark M., Alecu, Iulian, Vannucchi, Alessandro M.

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e18082-e18082

10.1200/jco.2015.33.15_suppl.e18082